Galbladder Cancer PDX Models

Suitable preclinical models such as Patient Derived Xenografts (PDX) are needed to evaluate therapies specifically targeting gallbladder cancer. PDX models are known to be the most predictive preclinical model and provide the most accurate approach to evaluating an agent’s efficacy prior to entering the clinic. The CrownBio gallbladder cancer PDX collection consists of several models, including models from both North American and Asian descent. More

Patient-derived xenografts (PDX) offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials.
CrownBio’s HuPrime® PDX collection well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL ID CANCER TYPE SUBTYPE models per page
GL0440 Galbladder Cancer ADC VIEW MODEL Details
GL0608 Galbladder Cancer ADC VIEW MODEL Details
GL0720 Galbladder Cancer ADC VIEW MODEL Details
GL11310 Galbladder Cancer NA VIEW MODEL Details
GL1208 Galbladder Cancer ADC VIEW MODEL Details
GL1418 Galbladder Cancer ADC VIEW MODEL Details
GL3014 Galbladder Cancer ADC VIEW MODEL Details
GL3379 Galbladder Cancer ADC VIEW MODEL Details
GL6899 Galbladder Cancer ADS VIEW MODEL Details